Literature DB >> 26468504

Continuing Challenges for the Clinical Laboratory for Detection of Carbapenem-Resistant Enterobacteriaceae.

Romney M Humphries1, James A McKinnell2.   

Abstract

Detecting carbapenem-resistant Enterobacteriaceae (CRE) can be difficult. In particular, the absence of FDA-cleared automated antimicrobial susceptibility test (AST) devices that use revised Clinical and Laboratory Standards Institute (CLSI) carbapenem breakpoints for Enterobacteriaceae and the lack of active surveillance tests hamper the clinical laboratory. In this issue of the Journal of Clinical Microbiology, Lau and colleagues (A. F. Lau, G. A. Fahle, M. A. Kemp, A. N. Jassem, J. P. Dekker, and K. M. Frank, J Clin Microbiol 53:3729-3737, 2015, http://dx.doi.org/10.1128/JCM.01921-15) evaluate the performance of a research-use-only PCR for the detection of CRE in rectal surveillance specimens.
Copyright © 2015, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26468504      PMCID： PMC4652095          DOI： 10.1128/JCM.02668-15

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  21 in total

1.  Comparison of meropenem MICs and susceptibilities for carbapenemase-producing Klebsiella pneumoniae isolates by various testing methods.

Authors:  Catharine C Bulik; Kathy A Fauntleroy; Stephen G Jenkins; Mayssa Abuali; Vincent J LaBombardi; David P Nicolau; Joseph L Kuti
Journal:  J Clin Microbiol       Date:  2010-05-19       Impact factor: 5.948

2.  Clinical microbiology costs for methods of active surveillance for Klebsiella pneumoniae carbapenemase-producing Enterobacteriaceae.

Authors:  Amy J Mathers; Melinda Poulter; Dawn Dirks; Joanne Carroll; Costi D Sifri; Kevin C Hazen
Journal:  Infect Control Hosp Epidemiol       Date:  2014-04       Impact factor: 3.254

3.  Carbapenem-resistant Enterobacteriaceae rectal screening during an outbreak of New Delhi metallo-β-lactamase-producing Klebsiella pneumoniae at an acute care hospital.

Authors:  Larissa M Pisney; M A Barron; E Kassner; D Havens; N E Madinger
Journal:  Infect Control Hosp Epidemiol       Date:  2014-04       Impact factor: 3.254

4.  Emergence and rapid regional spread of Klebsiella pneumoniae carbapenemase-producing Enterobacteriaceae.

Authors:  Sarah Y Won; L Silvia Munoz-Price; Karen Lolans; Bala Hota; Robert A Weinstein; Mary K Hayden
Journal:  Clin Infect Dis       Date:  2011-09       Impact factor: 9.079

5.  Prevalence and risk factors for acquisition of carbapenem-resistant Enterobacteriaceae in the setting of endemicity.

Authors:  Mahesh Swaminathan; Saarika Sharma; Stephanie Poliansky Blash; Gopi Patel; David B Banach; Michael Phillips; Vincent LaBombardi; Karen F Anderson; Brandon Kitchel; Arjun Srinivasan; David P Calfee
Journal:  Infect Control Hosp Epidemiol       Date:  2013-06-11       Impact factor: 3.254

6.  Antimicrobial-resistant pathogens associated with healthcare-associated infections: summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2009-2010.

Authors:  Dawn M Sievert; Philip Ricks; Jonathan R Edwards; Amy Schneider; Jean Patel; Arjun Srinivasan; Alex Kallen; Brandi Limbago; Scott Fridkin
Journal:  Infect Control Hosp Epidemiol       Date:  2012-11-27       Impact factor: 3.254

7.  Molecular epidemiology of KPC-producing Klebsiella pneumoniae isolates in the United States: clonal expansion of multilocus sequence type 258.

Authors:  Brandon Kitchel; J Kamile Rasheed; Jean B Patel; Arjun Srinivasan; Shiri Navon-Venezia; Yehuda Carmeli; Alma Brolund; Christian G Giske
Journal:  Antimicrob Agents Chemother       Date:  2009-06-08       Impact factor: 5.191

8.  The importance of long-term acute care hospitals in the regional epidemiology of Klebsiella pneumoniae carbapenemase-producing Enterobacteriaceae.

Authors:  Michael Y Lin; Rosie D Lyles-Banks; Karen Lolans; David W Hines; Joel B Spear; Russell Petrak; William E Trick; Robert A Weinstein; Mary K Hayden
Journal:  Clin Infect Dis       Date:  2013-08-14       Impact factor: 9.079

9.  Molecular dissection of an outbreak of carbapenem-resistant enterobacteriaceae reveals Intergenus KPC carbapenemase transmission through a promiscuous plasmid.

Authors:  Amy J Mathers; Heather L Cox; Brandon Kitchel; Hugo Bonatti; Ann Karen C Brassinga; Joanne Carroll; W Michael Scheld; Kevin C Hazen; Costi D Sifri
Journal:  MBio       Date:  2011-11-01       Impact factor: 7.867

10.  Vital signs: carbapenem-resistant Enterobacteriaceae.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2013-03-08       Impact factor: 17.586
View more
  6 in total

1.  PCR-Dipstick Chromatography for Differential Detection of Carbapenemase Genes Directly in Stool Specimens.

Authors:  Rathina Kumar Shanmugakani; Yukihiro Akeda; Norihisa Yamamoto; Noriko Sakamoto; Hideharu Hagiya; Hisao Yoshida; Dan Takeuchi; Yo Sugawara; Takuya Kodera; Mitsuo Kawase; Warawut Laolerd; Narong Chaihongsa; Pitak Santanirand; Yoshikazu Ishii; Shigeyuki Hamada; Kazunori Tomono
Journal:  Antimicrob Agents Chemother       Date:  2017-05-24       Impact factor: 5.191

2.  Impact of Delays between Clinical and Laboratory Standards Institute and Food and Drug Administration Revisions of Interpretive Criteria for Carbapenem-Resistant Enterobacteriaceae.

Authors:  Sarah M Bartsch; Susan S Huang; Kim F Wong; Rachel B Slayton; James A McKinnell; Daniel F Sahm; Krystyna Kazmierczak; Leslie E Mueller; John A Jernigan; Bruce Y Lee
Journal:  J Clin Microbiol       Date:  2016-08-31       Impact factor: 5.948

3.  Emergence of Ceftazidime-Avibactam Resistance Due to Plasmid-Borne blaKPC-3 Mutations during Treatment of Carbapenem-Resistant Klebsiella pneumoniae Infections.

Authors:  Ryan K Shields; Liang Chen; Shaoji Cheng; Kalyan D Chavda; Ellen G Press; Avin Snyder; Ruchi Pandey; Yohei Doi; Barry N Kreiswirth; M Hong Nguyen; Cornelius J Clancy
Journal:  Antimicrob Agents Chemother       Date:  2017-02-23       Impact factor: 5.191

4.  Use of Ancillary Carbapenemase Tests To Improve Specificity of Phenotypic Definitions for Carbapenemase-Producing Enterobacteriaceae.

Authors:  Shelley A Miller; Janet A Hindler; Angelo Chengcuenca; Romney M Humphries
Journal:  J Clin Microbiol       Date:  2017-03-29       Impact factor: 5.948

5.  Development of selective medium for IMP-type carbapenemase-producing Enterobacteriaceae in stool specimens.

Authors:  Norihisa Yamamoto; Ryuji Kawahara; Yukihiro Akeda; Rathina Kumar Shanmugakani; Hisao Yoshida; Hideharu Hagiya; Naohiro Hara; Isao Nishi; Satomi Yukawa; Rumiko Asada; Yumi Sasaki; Kazuhiro Maeda; Noriko Sakamoto; Shigeyuki Hamada; Kazunori Tomono
Journal:  BMC Infect Dis       Date:  2017-03-24       Impact factor: 3.090

Review 6.  Routine detection of carbapenem-resistant gram-negative bacilli in clinical laboratories. A review of current challenge.

Authors:  Ibrahim A Al-Zahrani
Journal:  Saudi Med J       Date:  2018-09       Impact factor: 1.484
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.